LabGenius, a London, UK-based drug discovery company, raised £35M in Series B funding. The round was led by M Ventures (the strategic, corporate venture capital arm of science and technology company Merck), with participation from additional new investors Octopus Ventures and LG Corp, together with existing investors including Atomico, Kindred Capital, Lux Capital and Obvious […]
The post LabGenius Raises £35M in Series B Funding appeared first on FinSMEs.